MyFinsight
Home
Blog
About
Net loss
-$153,224K
(-27.04%↓ Y/Y)
Loss before
provision for income taxes
-$153,224K
(-28.01%↓ Y/Y)
Interest income, net
$7,095K
(11.96%↑ Y/Y)
Other income, net
$4K
(-99.66%↓ Y/Y)
Total operating
expenses
$160,323K
(26.02%↑ Y/Y)
Research and development
$142,631K
(40.94%↑ Y/Y)
General and
administrative
$17,692K
(-32.02%↓ Y/Y)
Back
Back
Income Statement
IMVT_BIG-svg
Immunovant, Inc. (IMVT)
IMVT_BIG-svg
source: myfinsight.com
Immunovant, Inc. (IMVT)